(S)-nicotine increases expression ISO RGD:10091 6480464 Nicotine results in increased expression of ADK mRNA CTD PMID:17997037 1,2-dimethylhydrazine multiple interactions ISO RGD:10091 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADK mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:10091 6480464 1, 2-Dimethylhydrazine results in decreased expression of ADK mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:10091 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADK mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:737582 6480464 Estradiol affects the expression of ADK mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10091 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADK mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADK mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10091 6480464 Tetrachlorodibenzodioxin affects the expression of ADK mRNA CTD PMID:21570461 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ADK mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:10091 6480464 n-butoxyethanol results in increased expression of ADK mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:737582 6480464 Lactic Acid results in increased expression of ADK mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:737582 6480464 beta-methylcholine affects the expression of ADK mRNA CTD PMID:21179406 3-phenylprop-2-enal increases expression ISO RGD:737582 6480464 cinnamic aldehyde results in increased expression of ADK mRNA CTD PMID:19524605 4'-hydroxyacetophenone affects binding EXP 6480464 4-hydroxyacetophenone binds to ADK protein CTD PMID:15236443 4,4'-diaminodiphenylmethane affects expression ISO RGD:10091 6480464 4, 4'-diaminodiphenylmethane affects the expression of ADK mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide decreases expression ISO RGD:10091 6480464 Fenretinide results in decreased expression of ADK mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ADK mRNA CTD PMID:31881176 acetylsalicylic acid affects binding EXP 6480464 Aspirin binds to ADK protein CTD PMID:15236443 aflatoxin B1 affects expression ISO RGD:737582 6480464 Aflatoxin B1 affects the expression of ADK protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:737582 6480464 Aflatoxin B1 results in increased methylation of ADK intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:737582 6480464 Aflatoxin B1 results in decreased expression of ADK mRNA CTD PMID:21641981 aflatoxin B1 affects expression ISO RGD:10091 6480464 Aflatoxin B1 affects the expression of ADK mRNA CTD PMID:19770486 aflatoxin B2 increases methylation ISO RGD:737582 6480464 aflatoxin B2 results in increased methylation of ADK intron CTD PMID:30157460 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ADK mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:737582 6480464 Antirheumatic Agents results in increased expression of ADK mRNA CTD PMID:24449571 arsenous acid decreases expression ISO RGD:737582 6480464 Arsenic Trioxide results in decreased expression of ADK protein CTD PMID:25419056 benzo[a]pyrene decreases expression ISO RGD:10091 6480464 Benzoapyrene results in decreased expression of ADK mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO RGD:737582 6480464 Benzoapyrene results in decreased expression of ADK mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:10091 6480464 Benzoapyrene results in increased expression of ADK mRNA CTD PMID:22228805 Benzo[k]fluoranthene decreases expression ISO RGD:10091 6480464 benzokfluoranthene results in decreased expression of ADK mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of ADK mRNA CTD PMID:15651846 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADK mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:737582 6480464 bisphenol A results in decreased expression of ADK mRNA CTD PMID:29275510 cadmium atom multiple interactions ISO RGD:737582 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADK mRNA CTD PMID:31738976 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ADK promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:737582 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADK mRNA CTD PMID:31738976 cadmium sulfate multiple interactions ISO RGD:737582 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of ADK mRNA CTD PMID:18654764 carbon nanotube decreases expression ISO RGD:10091 6480464 Nanotubes, Carbon analog results in decreased expression of ADK mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:10091 6480464 Nanotubes more ... CTD PMID:25620056 cisplatin decreases expression ISO RGD:737582 6480464 Cisplatin results in decreased expression of ADK mRNA CTD PMID:19561079 clofibrate multiple interactions ISO RGD:10091 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ADK mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ADK mRNA] CTD PMID:17585979 clofibrate decreases expression ISO RGD:10091 6480464 Clofibrate results in decreased expression of ADK mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADK mRNA CTD PMID:17602206 cobalt dichloride multiple interactions ISO RGD:737582 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of ADK mRNA CTD PMID:18654764 cobalt dichloride decreases expression ISO RGD:737582 6480464 cobaltous chloride results in decreased expression of ADK mRNA CTD PMID:19376846 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ADK mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ADK mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:737582 6480464 Copper Sulfate results in decreased expression of ADK mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:737582 6480464 Coumestrol results in increased expression of ADK mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:10091 6480464 Cyclosporine results in decreased expression of ADK mRNA CTD PMID:19770486 diarsenic trioxide decreases expression ISO RGD:737582 6480464 Arsenic Trioxide results in decreased expression of ADK protein CTD PMID:25419056 dibutyl phthalate decreases expression ISO RGD:10091 6480464 Dibutyl Phthalate results in decreased expression of ADK mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:737582 6480464 Diclofenac results in increased expression of ADK mRNA CTD PMID:19022234 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of ADK mRNA CTD PMID:19022234 dicrotophos decreases expression ISO RGD:737582 6480464 dicrotophos results in decreased expression of ADK mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:737582 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ADK mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ADK mRNA CTD PMID:29391264 enilconazole increases expression ISO RGD:737582 6480464 enilconazole results in increased expression of ADK mRNA CTD PMID:32201337 enzyme inhibitor multiple interactions ISO RGD:737582 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ADK protein CTD PMID:23301498 ethanol affects splicing ISO RGD:10091 6480464 Ethanol affects the splicing of ADK mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:737582 6480464 Ethyl Methanesulfonate results in decreased expression of ADK mRNA CTD PMID:23649840 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ADK mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:10091 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADK mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:737582 6480464 Formaldehyde results in decreased expression of ADK mRNA CTD PMID:23649840 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ADK mRNA CTD PMID:24136188 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of ADK mRNA CTD PMID:20097248 kainic acid increases expression ISO RGD:10091 6480464 Kainic Acid results in increased expression of ADK mRNA CTD PMID:17997037 lead diacetate decreases expression ISO RGD:10091 6480464 lead acetate results in decreased expression of ADK mRNA CTD PMID:20542052 lead(II) chloride multiple interactions ISO RGD:737582 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of ADK mRNA CTD PMID:18654764 lithium atom increases expression EXP 6480464 Lithium results in increased expression of ADK protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of ADK protein CTD PMID:18296634 menadione affects expression ISO RGD:737582 6480464 Vitamin K 3 affects the expression of ADK mRNA CTD PMID:20044591 N-Acetyl-S-(1,2-dichlorovinyl)-cysteine increases expression ISO RGD:737582 6480464 S-1, 2-dichlorovinyl-N-acetylcysteine results in increased expression of ADK mRNA CTD PMID:16844155 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of ADK mRNA CTD PMID:20360939 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ADK mRNA CTD PMID:17602206 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of ADK protein CTD PMID:19716841 nickel atom multiple interactions ISO RGD:737582 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of ADK mRNA] CTD PMID:14575637 nickel atom affects expression ISO RGD:737582 6480464 Nickel affects the expression of ADK mRNA CTD PMID:14575637 nicotine increases expression ISO RGD:10091 6480464 Nicotine results in increased expression of ADK mRNA CTD PMID:17997037 O-methyleugenol decreases expression ISO RGD:737582 6480464 methyleugenol results in decreased expression of ADK mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ADK mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:10091 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ADK mRNA more ... CTD PMID:17585979 , PMID:25499718 paracetamol affects expression ISO RGD:10091 6480464 Acetaminophen affects the expression of ADK mRNA CTD PMID:17562736 perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of ADK protein CTD PMID:26168851 phenobarbital decreases expression ISO RGD:10091 6480464 Phenobarbital results in decreased expression of ADK mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:10091 6480464 Phenobarbital results in increased expression of ADK mRNA CTD PMID:31836555 Propiverine affects binding EXP 6480464 propiverine binds to ADK protein CTD PMID:29273565 protein kinase inhibitor multiple interactions ISO RGD:737582 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of ADK mRNA] CTD PMID:28003376 quercitrin decreases expression ISO RGD:737582 6480464 quercitrin results in decreased expression of ADK mRNA CTD PMID:25193878 rac-lactic acid increases expression ISO RGD:737582 6480464 Lactic Acid results in increased expression of ADK mRNA CTD PMID:30851411 ritodrine decreases expression ISO RGD:10091 6480464 Ritodrine results in decreased expression of ADK mRNA CTD PMID:23370008 SB 431542 multiple interactions ISO RGD:737582 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ADK mRNA CTD PMID:27188386 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ADK protein CTD PMID:29459688 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of ADK mRNA CTD PMID:22110744 sodium dichromate decreases expression ISO RGD:737582 6480464 sodium bichromate results in decreased expression of ADK mRNA CTD PMID:17685462 sodium fluoride decreases expression ISO RGD:10091 6480464 Sodium Fluoride results in decreased expression of ADK protein CTD PMID:28918527 Soman decreases expression EXP 6480464 Soman results in decreased expression of ADK mRNA CTD PMID:19281266 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of ADK mRNA CTD PMID:15885361 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ADK mRNA CTD PMID:25729387 trichostatin A multiple interactions ISO RGD:737582 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of ADK mRNA] CTD PMID:14575637 trichostatin A increases expression ISO RGD:737582 6480464 trichostatin A results in increased expression of ADK mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO RGD:10091 6480464 trimellitic anhydride results in increased expression of ADK mRNA CTD PMID:19042947 tungsten increases expression ISO RGD:10091 6480464 Tungsten results in increased expression of ADK mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:737582 6480464 Valproic Acid affects the expression of ADK mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:737582 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ADK mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737582 6480464 Valproic Acid results in increased expression of ADK mRNA CTD PMID:23179753 more ... vancomycin increases expression ISO RGD:10091 6480464 Vancomycin results in increased expression of ADK mRNA CTD PMID:18930951 vorinostat increases expression ISO RGD:737582 6480464 Vorinostat results in increased expression of ADK mRNA, Vorinostat results in increased expression of ADK protein CTD PMID:20543569 , PMID:27188386